Breaking News Instant updates and real-time market news.

ALGN

Align Technology

$269.46

-1.24 (-0.46%)

10:55
01/22/18
01/22
10:55
01/22/18
10:55

Align Technology put volume heavy and directionally bearish

Bearish flow noted in Align Technology with 1,513 puts trading, or 3x expected. Most active are Feb-18 250 puts and 1/26 weekly 250 puts, with total volume in those strikes near 600 contracts. The Put/Call Ratio is 1.88, while ATM IV is up nearly 2 points on the day. Earnings are expected on January 30th.

  • 30

    Jan

ALGN Align Technology
$269.46

-1.24 (-0.46%)

11/28/17
FBCO
11/28/17
NO CHANGE
Target $276
FBCO
Outperform
Align Technology price target raised to $276 from $261 at Credit Suisse
Credit Suisse analyst Erin Wilson Wright raised her price target for Align Technology to $276 from $261 saying there continues to be no end in sight for the company's "torrid growth," as management detailed DTC initiatives and financing programs that should fuel market traction among patients and practitioners, underappreciated dynamics. The analyst reiterates an Outperform rating on the shares.
12/04/17
LEER
12/04/17
NO CHANGE
LEER
Outperform
Leerink says Align Technology selloff a buying opportunity
Leerink analyst Richard Newitter said he suspects that Align Technology's underperformance today compared to the medical technology space is due to worries about competition after the CEO voiced that more of it is coming in 2018. However, this is nothing new and "nebulous stock moves on competition fears" will prove to be a buying opportunity, Newitter tells investors. The analyst, who said he came out of the recent meetings with company management more bullish on its near-term and long-term adoption prospects, reiterates an Outperform rating on Align Technology shares, which are down 9% to $231.05 in afternoon trading.
12/08/17
DBAB
12/08/17
INITIATION
Target $250
DBAB
Hold
Align Technology initiated with a Hold at Deutsche Bank
Deutsche Bank analyst Glen Santangelo started Align Technology with a Hold rating and $250 price target. The analyst cites valuation for his Hold rating.
01/19/18
SPHN
01/19/18
DOWNGRADE
Target $230
SPHN
Equal Weight
Align Technology downgraded to Equal Weight from Overweight at Stephens
Stephens analyst Chris Cooley downgraded Align Technology to Equal Weight from Overweight, citing valuation. While still expressing a high degree of confidence in the company's ability to deliver above consensus results in the near-term and successfully expand the market for clear aligner therapy in the long-term, Cooley notes that the company's $22B equity market valuation is approximately double the current $10B total addressable market and nearly in-line with the estimated expanded $20B total addressable market. He keeps a $230 price target on Align Technology shares.

TODAY'S FREE FLY STORIES

FBNK

First Connecticut

$26.05

0.15 (0.58%)

08:03
06/19/18
06/19
08:03
06/19/18
08:03
Hot Stocks
Breaking Hot Stocks news story on First Connecticut »

First Connecticut trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTC

PTC

$97.80

2.93 (3.09%)

, ANSS

Ansys

$177.91

0.17 (0.10%)

08:03
06/19/18
06/19
08:03
06/19/18
08:03
Recommendations
PTC, Ansys, Rockwell Automation analyst commentary  »

PTC price target raised…

PTC

PTC

$97.80

2.93 (3.09%)

ANSS

Ansys

$177.91

0.17 (0.10%)

ROK

Rockwell Automation

$175.40

-2.19 (-1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

NCR

NCR Corp.

$32.23

0.06 (0.19%)

08:03
06/19/18
06/19
08:03
06/19/18
08:03
Hot Stocks
NCR Corp. announces strategic alliance with TCS »

NCR Corp. announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DEA

Easterly Government Properties

$20.17

0.14 (0.70%)

08:03
06/19/18
06/19
08:03
06/19/18
08:03
Syndicate
Easterly Government Properties 18M share Spot Secondary priced at $19.25 »

The company increased the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

CLBS

Caladrius

$4.05

-0.015 (-0.37%)

08:02
06/19/18
06/19
08:02
06/19/18
08:02
Hot Stocks
Caladrius receives FDA RMAT designation for CD34+ cell therapy »

Caladrius Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBPO

China Biologic

$99.29

17.39 (21.23%)

08:02
06/19/18
06/19
08:02
06/19/18
08:02
Hot Stocks
China Biologic receives acquisition proposal from CCRE for $110 cash per share »

China Biologic announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XPO

XPO Logistics

$114.10

0.215 (0.19%)

08:02
06/19/18
06/19
08:02
06/19/18
08:02
Initiation
XPO Logistics initiated  »

XPO Logistics resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TREX

Trex Company

$64.61

1.675 (2.66%)

08:02
06/19/18
06/19
08:02
06/19/18
08:02
Hot Stocks
Trex Company announces effectiveness of 2-for-1 stock split »

Trex Company announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

G

Genpact

$30.84

-0.095 (-0.31%)

08:01
06/19/18
06/19
08:01
06/19/18
08:01
Hot Stocks
Genpact awarded patent for natural language understanding by USPTO »

Genpact announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ULH

Universal Logistics

$26.50

0.15 (0.57%)

08:01
06/19/18
06/19
08:01
06/19/18
08:01
Initiation
Universal Logistics initiated  »

Universal Logistics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

LSTR

Landstar System

$115.30

0.25 (0.22%)

08:00
06/19/18
06/19
08:00
06/19/18
08:00
Initiation
Landstar System initiated  »

Landstar System resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRTX

Mirati Therapeutics

$49.15

0.3 (0.61%)

08:00
06/19/18
06/19
08:00
06/19/18
08:00
Recommendations
Mirati Therapeutics analyst commentary  »

Mirati Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

ECHO

Echo Global

$30.40

-0.15 (-0.49%)

08:00
06/19/18
06/19
08:00
06/19/18
08:00
Initiation
Echo Global initiated  »

Echo Global resumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

CHRW

C.H. Robinson

$90.67

0.57 (0.63%)

07:59
06/19/18
06/19
07:59
06/19/18
07:59
Initiation
C.H. Robinson initiated  »

C.H. Robinson resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

TTPH

Tetraphase

$4.20

-0.05 (-1.18%)

07:59
06/19/18
06/19
07:59
06/19/18
07:59
Conference/Events
Tetraphase has a conference call hosted by SunTrust »

SunTrust will host a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 25

    Jun

  • 28

    Aug

BTE

Baytex Energy

$3.40

-0.47 (-12.16%)

07:56
06/19/18
06/19
07:56
06/19/18
07:56
Upgrade
Baytex Energy rating change  »

Baytex Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$14.05

(0.00%)

07:56
06/19/18
06/19
07:56
06/19/18
07:56
Recommendations
Snap analyst commentary  »

Snap survey shows usage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:55
06/19/18
06/19
07:55
06/19/18
07:55
General news
U.S. chain store sales rose 1.4% in the week ended June 16 »

U.S. chain store sales…

HSGX

Histogenics

$2.87

-0.1 (-3.37%)

07:55
06/19/18
06/19
07:55
06/19/18
07:55
Conference/Events
Histogenics to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

TDG

TransDigm

$340.12

0.06 (0.02%)

07:54
06/19/18
06/19
07:54
06/19/18
07:54
Recommendations
TransDigm analyst commentary  »

TransDigm poised to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

MDGL

Madrigal Pharmaceuticals

$306.24

6.23 (2.08%)

, BMY

Bristol-Myers

$53.65

-1.155 (-2.11%)

07:54
06/19/18
06/19
07:54
06/19/18
07:54
Downgrade
Madrigal Pharmaceuticals, Bristol-Myers, Nektar rating change  »

Madrigal cut to In Line…

MDGL

Madrigal Pharmaceuticals

$306.24

6.23 (2.08%)

BMY

Bristol-Myers

$53.65

-1.155 (-2.11%)

NKTR

Nektar

$58.40

0.545 (0.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 10

    Jul

RHT

Red Hat

$176.26

1.27 (0.73%)

07:53
06/19/18
06/19
07:53
06/19/18
07:53
Downgrade
Red Hat rating change  »

Red Hat downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

GLT

Glatfelter

$18.95

0.1 (0.53%)

07:49
06/19/18
06/19
07:49
06/19/18
07:49
Hot Stocks
Glatfelter to acquire Georgia-Pacific's European nonwovens business for $185M »

Glatfelter announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLUE

Bluebird Bio

$176.50

-6.25 (-3.42%)

, CELG

Celgene

$77.71

-0.38 (-0.49%)

07:48
06/19/18
06/19
07:48
06/19/18
07:48
Upgrade
Bluebird Bio, Celgene rating change  »

Bluebird Bio upgraded to…

BLUE

Bluebird Bio

$176.50

-6.25 (-3.42%)

CELG

Celgene

$77.71

-0.38 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OBSV

ObsEva

$17.21

2.68 (18.44%)

07:48
06/19/18
06/19
07:48
06/19/18
07:48
Recommendations
ObsEva analyst commentary  »

ObsEva price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.